Jefferies Group LLC Innoviva, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $10.2 Million - $13.5 Million	-665,000 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$15.91 - $18.72 $1.38 Million - $1.62 Million	86,800 Added 15.01%	665,000 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.38 Million - $1.62 Million	86,800 Added 15.01%	665,000 $11.5 Million
Q2 2021 Sep 21, 2023	BUY	$11.45 - $13.96 $1 Million - $1.22 Million	87,500 Added 17.83%	578,200 $7.75 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $1 Million - $1.22 Million	87,500 Added 17.83%	578,200 $7.75 Million
Q4 2020 Sep 21, 2023	BUY	$9.33 - $12.48 $4.58 Million - $6.12 Million	490,700 New	490,700 $6.08 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $2.04 Million - $2.73 Million	218,700 Added 80.4%	490,700 $6.08 Million
Q3 2020 Nov 13, 2020	BUY	$10.33 - $14.49 $764,172 - $1.07 Million	73,976 Added 37.36%	272,000 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $2.28 Million - $3.02 Million	198,024 New	198,024 $2.77 Million
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $410,195 - $770,318	-50,579 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $169,938 - $237,715	16,531 Added 48.55%	50,579 $716,000
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $284,626 - $412,070	-28,321 Reduced 45.41%	34,048 $359,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $181,552 - $207,192	-13,859 Reduced 18.18%	62,369 $908,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $1.26 Million - $1.85 Million	-92,247 Reduced 54.75%	76,228 $1.07 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $1.5 Million - $1.96 Million	107,433 Added 176.0%	168,475 $2.94 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $832,002 - $958,359	61,042 New	61,042 $930,000
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $187,582 - $245,503	-13,957 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $192,606 - $237,129	13,957 New	13,957 $233,000
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $136,912 - $172,162	-11,672 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $140,764 - $164,808	11,672	11,672 $165,000

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$184 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$139 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$129 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$120 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$119 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account